BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Li Y, Mandrekar SJ, Yang P. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol 2011;6:291-5. [PMID: 21173712 DOI: 10.1097/JTO.0b013e31820213fb] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Tubío-Pérez RA, Torres-Durán M, Fernández-Villar A, Ruano-Raviña A. Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review. Transl Oncol 2021;14:100914. [PMID: 33142121 DOI: 10.1016/j.tranon.2020.100914] [Reference Citation Analysis]
2 Pérez-Holanda S, Blanco I, Menéndez M, Rodrigo L. Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. BMC Cancer 2014;14:355. [PMID: 24886427 DOI: 10.1186/1471-2407-14-355] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
3 El-Akawi ZJ, Abu-Awad AM, Khouri NA. Alpha-1 Antitrypsin Blood Levels as Indicator for the Efficacy of Cancer Treatment. World J Oncol 2013;4:83-6. [PMID: 29147336 DOI: 10.4021/wjon663e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Li Y, Miao L, Yu M, Shi M, Wang Y, Yang J, Xiao Y, Cai H. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression. Int J Oncol 2017;50:1955-64. [PMID: 28440399 DOI: 10.3892/ijo.2017.3962] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
5 Cavalcante Mde S, Torres-Romero JC, Lobo MD, Moreno FB, Bezerra LP, Lima DS, Matos JC, Moreira Rde A, Monteiro-Moreira AC. A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia. Biomark Res 2016;4:1. [PMID: 26823978 DOI: 10.1186/s40364-016-0055-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
6 Qu X, Pang Z, Yi W, Wang Y, Wang K, Liu Q, Du J. High percentage of α1-globulin in serum protein is associated with unfavorable prognosis in non-small cell lung cancer. Med Oncol 2014;31:238. [PMID: 25216870 DOI: 10.1007/s12032-014-0238-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 de Andrade M, Li Y, Marks RS, Deschamps C, Scanlon PD, Olswold CL, Jiang R, Swensen SJ, Sun Z, Cunningham JM. Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev Res (Phila). 2012;5:365-373. [PMID: 22044695 DOI: 10.1158/1940-6207.capr-11-0243] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
8 Perincek G, Avcı S. Evaluation of alpha-1-antitrypsin levels in blood serum of patients with chronic obstructive pulmonary disease. Acta Biomed 2018;90:37-43. [PMID: 30889153 DOI: 10.23750/abm.v90i1.6780] [Reference Citation Analysis]
9 Najafi Z, Mohamadnia A, Ahmadi R, Mahmoudi M, Bahrami N, Khosravi A, Jamaati H, Tabarsi P, Kazem Pour Dizaji M, Shirian S. Proteomic and genomic biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 antitrypsin. Cancer Med 2020;9:3974-82. [PMID: 32232956 DOI: 10.1002/cam4.3019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]